Fredun Pharmaceuticals share news, announcements and annual reports
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,453.50.
30 Oct: open ₹1,455.00, high ₹1,467.90, low ₹1,360.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,310 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 53,67255.3% delivered
Fredun Pharmaceuticals share news and announcements
664 announcements, routine notices left out, newest first. Page 3 of 14.
Oct 2025
28 Oct · Board meeting
Meeting on 8 Nov 2025: quarterly results13 Oct · Business
9 Oct · Business
6 Oct · Management
Sep 2025
30 Sep · Corporate action
30 Sep · Meeting
30 Sep · Management
30 Sep · Management
22 Sep · Board meeting
Meeting on 25 Sep 2025: issue of warrants and preferential issue of shares8 Sep · Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").
8 Sep · Meeting
8 Sep · Submission Of The 38Th Annual Report Of Fredun Pharmaceuticals Limited For The Financial Year 2024-25.
2 Sep · Announcement under Regulation 30 (LODR)-Meeting Updates
Aug 2025
Jul 2025
31 Jul · Business
30 Jul · Management
14 Jul · Board meeting
Meeting on 30 Jul 2025: quarterly results
Jun 2025
20 Jun · Announcement under Regulation 30 (LODR)-Demise
10 Jun · Investors Presentation Issued By Fredun Pharmaceuticals Limited Stating Annual Review & Strategic Outlook For Growth In The Pharma Industry
May 2025
31 May · Board meeting
22 May · Board meeting
Meeting on 30 May 2025: audited results and dividend17 May · Management
17 May · Management
Apr 2025